Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
Ziyan Wang, Jiao An, Kunpeng Liu, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 14

Showing 14 citing articles:

A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
Lorena M. Coria, Juan M. Corchado, Agostina Demaría, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Progress with COVID vaccine development and implementation
Richard W. Titball, David I. Bernstein, Nicolas V. J. Fanget, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
In-depth characterization of protein N-glycosylation for a COVID-19 variant-design vaccine spike protein
Jiangming Huang, Shouzeng Hou, Jiao An, et al.
Analytical and Bioanalytical Chemistry (2023) Vol. 415, Iss. 8, pp. 1455-1464
Open Access | Times Cited: 8
Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters
Yolandy Lemmer, Rosamund Chapman, Célia Abolnik, et al.
Vaccine (2024) Vol. 42, Iss. 4, pp. 738-744
Open Access | Times Cited: 2
Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
Vaccine (2024) Vol. 42, Iss. 20, pp. 125980-125980
Open Access | Times Cited: 2
Evaluation of Multiplex Rapid Antigen Tests for the Simultaneous Detection of SARS-CoV-2 and Influenza A/B Viruses
Ho Jae Lim, Ji Yoon Lee, Young-Hyun Baek, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3267-3267
Open Access | Times Cited: 6
Efficacy of a Stable Broadly Protective Subunit Vaccine Platform Against Sars-Cov-2 Variants of Concern
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
(2024)
Closed Access | Times Cited: 1
A Gamma-adapted recombinant subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
Lorena M. Coria, Juan M. Corchado, Agostina Demaría, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trial
Guang-Wei Feng, Zhongfang Wang, Peng He, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 2
Safety and immunogenicity of different booster vaccination schemes for COVID-19 used in El Salvador
Xochitl Sandoval López, Rhina Domínguez, Delmy Lisseth Recinos, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 1, pp. 35-35
Open Access
Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice
Ahmedali S. Mandviwala, Anke Huckriede, Vidya A. Arankalle, et al.
Virology (2024) Vol. 598, pp. 110194-110194
Open Access
Safety, reactogenicity, and immunogenicity of ZR-202-CoV and ZR-202a-CoV recombinant vaccines compared with Comirnaty®: a randomized, observer-blind, controlled, phase 1 study.
Samba O. Sow, Milagritos D. Tapia, Fadima Cheick Haidara, et al.
International Journal of Infectious Diseases (2024), pp. 107237-107237
Open Access
Safety and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine as a booster against SARS-CoV-2: a phase II, open-label, randomized, double-blinded study
Rachael Song-Qi Lim, Xiangyan Qiu, Edison Alberto, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 4, pp. 329-329
Open Access
Efficacy of a stable multivalent broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern
Arinjay Banerjee, Ravendra Garg, Qiang Liu, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top